155 related articles for article (PubMed ID: 30454953)
1. Avian leukosis virus subgroup - J as a contaminant in live commercially available poultry vaccines distributed in Nigeria.
Shittu I; Adedeji AJ; Luka PD; Asala OO; Sati NM; Nwagbo IO; Chinyere CN; Arowolo OO; Adole JA; Emennaa P; Abdu PA; Joannis TM
Biologicals; 2019 Jan; 57():29-33. PubMed ID: 30454953
[TBL] [Abstract][Full Text] [Related]
2. Full-length genome sequence analysis of an avian leukosis virus subgroup J (ALV-J) as contaminant in live poultry vaccine: The commercial live vaccines might be a potential route for ALV-J transmission.
Wang P; Lin L; Li H; Shi M; Gu Z; Wei P
Transbound Emerg Dis; 2018 Aug; 65(4):1103-1106. PubMed ID: 29479824
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Marek's Disease Virus as a Vector-Based Vaccine against Avian Leukosis Virus Subgroup J in Chicken.
Liu Y; Li K; Gao Y; Gao L; Zhong L; Zhang Y; Liu C; Zhang Y; Wang X
Viruses; 2016 Nov; 8(11):. PubMed ID: 27827933
[TBL] [Abstract][Full Text] [Related]
4. Isolation, identification, and gp85 characterization of a subgroup A avian leukosis virus from a contaminated live Newcastle Disease virus vaccine, first report in China.
Zhao P; Dong X; Cui Z
Poult Sci; 2014 Sep; 93(9):2168-74. PubMed ID: 25002550
[TBL] [Abstract][Full Text] [Related]
5. Recombinant subgroup B avian leukosis virus combined with the subgroup J env gene significantly increases its pathogenicity.
Li Q; Wang P; Li M; Lin L; Shi M; Li H; Deng Q; Teng H; Mo M; Wei T; Wei P
Vet Microbiol; 2020 Nov; 250():108862. PubMed ID: 33007608
[TBL] [Abstract][Full Text] [Related]
6. Avian leukosis virus contamination in live vaccines: A retrospective investigation in China.
Mao Y; Su Q; Li J; Jiang T; Wang Y
Vet Microbiol; 2020 Jul; 246():108712. PubMed ID: 32605749
[TBL] [Abstract][Full Text] [Related]
7. Development of a polymerase chain reaction to differentiate avian leukosis virus (ALV) subgroups: detection of an ALV contaminant in commercial Marek's disease vaccines.
Silva RF; Fadly AM; Taylor SP
Avian Dis; 2007 Sep; 51(3):663-7. PubMed ID: 17992923
[TBL] [Abstract][Full Text] [Related]
8. Isolation, identification, and phylogenetic analysis of two avian leukosis virus subgroup J strains associated with hemangioma and myeloid leukosis.
Li Y; Liu X; Liu H; Xu C; Liao Y; Wu X; Cao W; Liao M
Vet Microbiol; 2013 Oct; 166(3-4):356-64. PubMed ID: 23876931
[TBL] [Abstract][Full Text] [Related]
9. Reduced serologic response to Newcastle disease virus in broiler chickens exposed to a Chinese field strain of subgroup J avian leukosis virus.
Cui Z; Sun S; Wang J
Avian Dis; 2006 Jun; 50(2):191-5. PubMed ID: 16863066
[TBL] [Abstract][Full Text] [Related]
10. The effects of cyclophosphamide treatment on the pathogenesis of subgroup J avian leukosis virus (ALV-J) infection in broiler chickens with Marek's disease virus exposure.
Kim Y; Brown TP; Pantin-Jackwood MJ
J Vet Sci; 2004 Mar; 5(1):49-58. PubMed ID: 15028885
[TBL] [Abstract][Full Text] [Related]
11. [Mono-specific serum preparation and specificity of gp85 gene of subgroup A avian leukosis virus].
Zhang H; Li C; Yang M; Cui Z
Wei Sheng Wu Xue Bao; 2011 Jan; 51(1):134-40. PubMed ID: 21465800
[TBL] [Abstract][Full Text] [Related]
12. Single and concurrent avian leukosis virus infections with avian leukosis virus-J and avian leukosis virus-A in Australian meat-type chickens.
Fenton SP; Reddy MR; Bagust TJ
Avian Pathol; 2005 Feb; 34(1):48-54. PubMed ID: 15763738
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel B-cell epitope specific for avian leukosis virus subgroup J gp85 protein.
Li X; Zhu H; Wang Q; Sun J; Gao Y; Qi X; Wang Y; Gao H; Gao Y; Wang X
Arch Virol; 2015 Apr; 160(4):995-1004. PubMed ID: 25655260
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of an autophagy-targeted DNA vaccine against avian leukosis virus subgroup J.
Dai Z; Huang J; Lei X; Yan Y; Lu P; Zhang H; Lin W; Chen W; Ma J; Xie Q
Vaccine; 2017 Feb; 35(5):808-813. PubMed ID: 28049588
[TBL] [Abstract][Full Text] [Related]
15. Detection and characterization of avian leukosis virus in Marek's disease vaccines.
Zavala G; Cheng S
Avian Dis; 2006 Jun; 50(2):209-15. PubMed ID: 16863069
[TBL] [Abstract][Full Text] [Related]
16. Preparation of the Secretory Recombinant ALV-J gp85 Protein Using Pichia pastoris and Its Immunoprotection as Vaccine Antigen Combining with CpG-ODN Adjuvant.
Jing W; Zhou J; Wang C; Qiu J; Guo H; Li H
Viral Immunol; 2018; 31(6):407-416. PubMed ID: 29698128
[TBL] [Abstract][Full Text] [Related]
17. Isolation and characterization of an adventitious avian leukosis virus isolated from commercial Marek's disease vaccines.
Fadly A; Silva R; Hunt H; Pandiri A; Davis C
Avian Dis; 2006 Sep; 50(3):380-5. PubMed ID: 17039837
[TBL] [Abstract][Full Text] [Related]
18. Subgroup J avian leukosis virus neutralizing antibody escape variants contribute to viral persistence in meat-type chickens.
Pandiri AR; Mays JK; Silva RF; Hunt HD; Reed WM; Fadly AM
Avian Dis; 2010 Jun; 54(2):848-56. PubMed ID: 20608529
[TBL] [Abstract][Full Text] [Related]
19. A novel multi-variant epitope ensemble vaccine against avian leukosis virus subgroup J.
Wang X; Zhou D; Wang G; Huang L; Zheng Q; Li C; Cheng Z
Vaccine; 2017 Dec; 35(48 Pt B):6685-6690. PubMed ID: 29054728
[TBL] [Abstract][Full Text] [Related]
20. A recombination efficiently increases the pathogenesis of the novel K subgroup of avian leukosis virus.
Lv L; Li T; Hu M; Deng J; Liu Y; Xie Q; Shao H; Ye J; Qin A
Vet Microbiol; 2019 Apr; 231():214-217. PubMed ID: 30955812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
